Showing 421-430 of 472 results for "".
CMS 2015 - Putting Your Money Where Their Mouth Is
https://practicaldermatology.com/topics/practice-management/cms-2015---putting-your-money-where-their-mouth-is/21205/Saving Medical Dermatology: Biologics and the Future of Patient Care
https://practicaldermatology.com/topics/practice-management/saving-medical-dermatology-biologics-and-the-future-of-patient-care/21211/Although prescription rates lag, biologic agents may hold the key to sustaining the specialty.Customize Online Content to Suit Your Target Audience
https://practicaldermatology.com/topics/practice-management/customize-online-content-to-suit-your-target-audience/21256/You can generate maximum impact for your practice when you create customized content with a sharp focus on your target audience.Preparation: The Cornerstone for Effective, Efficient EHR Use
https://practicaldermatology.com/topics/practice-management/preparation-the-cornerstone-for-effective-efficient-ehr-use/21269/Finding Meaning in a Complicated EHR Picture
https://practicaldermatology.com/topics/practice-management/finding-meaning-in-a-complicated-ehr-picture/21302/Introducing the next edition of the EHR User series, featuring perspective on individual systems and the broader HIT picture.Tips for Increasing Practice Efficiency
https://practicaldermatology.com/topics/practice-management/tips-for-increasing-practice-efficiency/21405/How to stay on schedule and keep patients, staff, and physicians happy.Analyzing Risk Factors for Subsequent Primary Melanomas
https://practicaldermatology.com/topics/skin-cancer-photoprotection/analyzing-risk-factors-for-subsequent-primary-melanomas/21429/Charging Toward Stage 2 of Meaningful Use
https://practicaldermatology.com/topics/practice-management/charging-toward-stage-2-of-meaningful-use/21467/As the next stage of the Federal EHR incentive program is set to begin, the forecast remains uncertain.SPF Recommendations: Should They Change?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/spf-recommendations-should-they-change/21475/What is the minimum SPF dermatologists should be recommending to their patients?Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.